ALDH1 Is An Independent Prognostic Factor For Patients With Stages II–III Rectal Cancer After Receiving Radiochemotherapy

Below is result for ALDH1 Is An Independent Prognostic Factor For Patients With Stages II–III Rectal Cancer After Receiving Radiochemotherapy in PDF format. You can download or read online all document for free, but please respect copyrighted ebooks. This site does not host PDF files, all document are the property of their respective owners.

Compilation of abstract titles from ASCO Annual Meeting 2021

28 Apr 2021 Phase II study of preoperative (PREOP) chemoradiotherapy (CTRT) plus avelumab. (AVE) in patients (PTS) with locally advanced rectal cancer 

Identification of a Nervous System Gene Expression - bioRxiv

oleh JL Regan 2021 ALDH1 is an independent prognostic factor for patients with stages. 540. II-III rectal cancer after receiving radiochemotherapy.

Supplement 2, Proceedings of the 14th World Conference on

oleh RU Osarogiagbon 2011 5 patients of the 13 patients who were stage II or III radiation therapy are independent prognostic factors. (P<0.05).

PDF 3.57 MB - Iranian Journal of Pathology

oleh M Rezaee 2021 ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy. Br J Cancer.

Appendix H. Excluded Studies - Washington State Health

21 Feb 2018 associated stroma are independent prognostic factors in a retrospective study of early-stage hormone- negative breast cancer.

Aldehyde dehydrogenase 1 A1 is expressed by cancer stem

oleh A Schäfer Stable and specific knockdown of ALDH1A1 in glioblastoma cell lines by enzyme and an unfavorable outcome, independently of the patients' MGMT status.

The role of cancer stem cells in tumor heterogeneity - TSpace

oleh C Konrad Dirujuk 29 kali 2014. ALDH1 is an independent prognostic. 816 factor for patients with stages II III rectal cancer after receiving radiochemotherapy.

Time to lowest postoperative carcinoembryonic antigen level

oleh H Yu Dirujuk 4 kali We enrolled 155 rectal cancer patients in this retrospective and CEA level as an independently predictive factor of recurrence and 

Biological and Clinical Parameters to Improve Outcome in

oleh E Toxopeus 2019 and carboplatin for patients with oesophageal cancer: a phase II study. and pR-stage were independent prognostic factors for survival 

Oncologia, Ematologia e Patologia - AMS Dottorato

oleh G Venturi 2018 ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy. Br J Cancer 110, 430-434 (2014).

Acquisition of Cancer Stem Cell Behaviour Plays a Role in

21 Jan 2015 (2014) ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy.

Enhancement of Sensitivity to Chemo/Radiation - Cell Press

oleh D Ji 2018 Dirujuk 25 kali Up to 90% of patients with colorectal cancer (CRC) can outcomes in patients with stage I, II, and III CRC treated.

ROLE OF BUBBLE-BASED NANOSYSTEMS IN - ShareOK

oleh JP VanOsdol 2020 Colon cancer biology, and the role for chemo-immunotherapy with HIFU and ALDH1 is an independent prognostic factor for patients with stages II-III.

Targeting Cancer Stem Cells to Overcome - HAL-Inserm

oleh T Nunes 2018 Dirujuk 66 kali In a phase II study of patients with progressive factor for patients with stages II-III rectal cancer after receiving radiochemotherapy.

276 Öz Abstract ARAŞTIRMA Genel Tıp Dergisi

Deng Y, Zhou J, Fang L, et al., ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy.

DGHO2008 Abstracts:DGHO2008 Abstracts.qxd.qxd

30 Apr 2008 Prognostic factors with independent significant information rience in the monitoring of patients receiving treatment with imatinib 

University of Groningen Response evaluation of

As is given in the TNM staging, the prognosis of esophageal cancer patients lymph node (LN) ratio >0.20 were independent prognostic factors for survival.

A combined strategy of SAGE and quantitative PCR provides

oleh E Casado 2011 Dirujuk 30 kali Rectal cancer, gene signature, preoperative chemoradiotherapy response, The patients had clinical stage II and III adenocarcinoma.

Network Mapping of Molecular Biomarkers Influencing

oleh L Poynter Dirujuk 6 kali Abstract. Preoperative radiotherapy (RT) plays an important role in the management of locally advanced rectal cancer (RC). Tumor regression after RT shows 

Colorectal Cancer - Cloud Object Storage Store & Retrieve

Phase II study of ipilimumab, nivolumab, and panitumumab in patients with Prognostic value of tumor deposits in stage III colon cancer patients, 

Jaffer A. Ajani, MD - FDA

25 Apr 2019 Principal Investigator, Phase II study of 120-hour Taxol infusion in patients with treated advanced colorectal carcinoma, DM93-015, 1994, 

Influence of the human papillomavirus on the radio - Nature

oleh P Reid 2020 Dirujuk 3 kali ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy. Br. J. Cancer 110, 430 434, 

Identification of cancer stem cells in cell lines - IS MUNI

oleh J Škoda Dirujuk 1 kali ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy. Br J Cancer 110, 430-434.

Optimizing the treatment of oesophageal cancer - Maastricht

1 Jan 2020 followed by surgery for stage II to III esophageal squamous cell carcinoma. radiation therapy target volume: a new prognostic factor for 

Molecular profiling of ALDH1+ colorectal cancer stem cells

oleh R Vishnubalaji Dirujuk 34 kali Huang M, Wang J. ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy. Br J Cancer.

Putative stem cell markers in cervical squamous cell

oleh T Hou 2015 Dirujuk 40 kali ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy. Br J Cancer. 2014;110(2):430 4.

Pathologic assessment and predictors of radioresponsiveness

surgery, stage of tumour and degree of treatment response in the surgical clinically important prognostic factor in patients receiving neoadjuvant.

Cancer stem cells in colorectal cancer: a review - Journal of

oleh MJ Munro 2018 Dirujuk 134 kali ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy. Br J Cancer.

International Poster Session 第61巻Supplement2号 - J-Stage

vanced gastric cancers)from the patients who had received radi- cal gastric resection. markers in prognosis of gastric cancer had limited values. Only,.

Aldehyde Dehydrogenase 1 (aldh1) Genes In - EliScholar

oleh M Ding 2016 can be a predictor of poor prognosis among cancer patients [24]. However, among the ALDH1-positive clinical stage II/III patients, 

The prognostic value of clinical factors and cancer stem cell

oleh RH Dahlrot Dirujuk 21 kali High grade glioma patients often have a poor prognosis despi- te aggressive treatment [2], which in combination with a growing number of patients, more focus on 

ALDH1 is an independent prognostic factor for - Ebsco

oleh Y Deng 2014 Dirujuk 64 kali ALDH1 is an independent prognostic factor for patients with stages II III rectal cancer after receiving radiochemotherapy.

Mutant p53 gain of function underlies high expression - Nature

oleh H Solomon 2018 Dirujuk 56 kali ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy. Br J Cancer.

Phase II Clinical Trial of Concurrent Neoadjuvant

oleh M Brackstone 2015 breast cancers, with an overall poor prognosis, despite current guidelines A number of tumour and patient factors determine the risk of 

AbstrACt bOOk - German Cancer Research Center

16 Feb 2018 independent of prognostic factors such as tumor size, number of affected nodes, metabolites in stage II colorectal cancer patients.

Download - University of Bradford eThesis

oleh LMI Elsalem 2017 et al. 2014 showed that ALDH1 is an independent prognostic factor for patients with stages II III rectal cancer after receiving radio-chemotherapy.

Molecular profiling of ALDH1+ colorectal cancer stem cells

oleh R Vishnubalaji Dirujuk 34 kali Huang M, Wang J. ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy. Br J Cancer.

The identifications and clinical implications of cancer - CORE

oleh SMR Wahab Dirujuk 64 kali for the better management of patients with colorectal carcinoma. an independent prognostic factor for patients with stages II-III rectal cancer after.

LiFE Literature for ENYGO - European Society of

All stage IV patients had received 4-8 cycles of neoadjuvant chemo- ovarian cancer: Analysis of prognostic factors related to overall survival and.

Clinical relevance of EMT and stem-like gene expression in

oleh Y Ning 2018 Dirujuk 28 kali ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy. Br J Cancer 2014; 

Oxidative stress in the pathogenesis and prognosis of - Jultika

oleh M Pylväs-Eerola prognostic factor in endometrioid-type epithelial ovarian cancer. prognostic factor for patients with stages II III rectal cancer after.

Gene Section - Revues et Congrès - Inist

oleh E Yavuz 2018 Dirujuk 1 kali M, Wang J. ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy. Br J Cancer.

Cancer Stem Cell Properties as Factors Predictive of

oleh M PYLVÄS-EEROLA 2016 Dirujuk 20 kali and Wang J: ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy. Br J Cancer 110(2): 

Prognostic Value of Cancer Stem Cell Marker ALDH1 - PLOS

oleh J Chen 2015 Dirujuk 60 kali ALDH1 is an independent prognostic factor for patients with stages II III rectal cancer after receiving radiochemotherapy.

PDF PDF - De Gruyter

oleh CA Ledesma Analysis of the diagnostic utility of AFP and PIVKA-II in the study of hepatocellular carcinoma value for prognosis of urothelial carcinoma patients.

Abstract Book ESMO 22nd World Congress on

10 Feb 2020 nosed with stage III colorectal cancer (64.5%). than 20 mm (p < 0001) was an independent prognostic factor of LTPFS (HR 3.71;.

Thrombosis in Colorectal Cancer - Research Explorer - The

oleh HW Clouston 2016 ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy. Br J Cancer 2014;110(2):430-4.

Putative stem cell markers in cervical squamous cell

oleh T Hou 2015 Dirujuk 40 kali ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy. Br J Cancer. 2014;110(2):430 4.

Expression of Aldehyde Dehydrogenase (ALDH1) and ATP

oleh NA Mahmood 2018 Dirujuk 4 kali ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy. Br J Cancer 2014;110:430-4.

The shifting paradigm of colorectal cancer treatment - Taylor

10 Mei 2021 ALDH1 is an independent prognostic factor for patients with stages II III rectal cancer after receiving radiochemotherapy. Br J Cancer.